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ABSTRACT 
 
Dynamic modifications of synaptic connectivity enables the brain to 
adequately respond to environmental challenges. This ability, known as 
synaptic plasticity, peaks during the early postnatal period, yet it is 
maintained throughout life. Interestingly, antidepressants (ADs) and AD-like 
drugs can promote neuronal plasticity in the adult brain, a phenomenon 
recently suggested to contribute to the mood-improving effects of ADs. 
However, the mechanisms underlying AD-induced neuronal network 
refinement are still poorly understood. 
The main goal of this thesis was to advance our understanding of the 
mechanisms associated with pharmacologically-enhanced plasticity in the 
adult brain. Two pharmacologically distinct compounds with AD-like actions, 
namely the selective serotonin reuptake inhibitor fluoxetine (Flx) and the 
volatile anesthetic isoflurane were used to enhance synaptic plasticity in the 
rodent cortex and hippocampus. After drug exposure, behavioral, molecular, 
histological and in vitro electrophysiological approaches were utilized to 
investigate the effects of Flx and ISO on synaptic function and plasticity. Using 
electrophysiological recordings in brain slices, we show that chronic Flx 
treatment results in increased short- and long-term plasticity as well as 
enhanced basal transmission in excitatory CA3-CA1 synapses in the 
hippocampus. These changes were paralleled by an activity-dependent 
enhancement in the expression of proteins related to vesicular trafficking and 
release, such as synaptophysin, synaptotagmin 1, mammalian uncoordinated 
protein 18 (Munc 18) and syntaxin 1. Moreover, Flx treatment reduced the 
percentage of parvalbumin-expressing GABAergic neurons, increased the 
expression of polysialylated-neural cell adhesion molecule (PSA-NCAM) and 
decreased the expression of the potassium-chloride co-transporter 2 (KCC2) 
in the basolateral amygdala and in the medial prefrontal cortex (mPFC). All 
the above findings are likely to be attributed to increased dynamic range of 
synaptic plasticity induced by Flx. Our behavioral findings demonstrate that 
long term Flx administration in combination with extinction training results 
in long-term loss of fearful memories while the Flx treatment alone failed to 
influence fear behavior. These data suggest that behavioral training is 
indispensable for the guidance of Flx-induced network plasticity.  
Exposure to isoflurane promotes long-term synaptic plasticity and enhances 
basal synaptic transmission in excitatory CA3-CA1 synapses in the mouse 
hippocampus. These changes were correlated with increased tropomyosin 
receptor kinase B (TrkB) signaling through the mammalian target of 
rapamycin (mTOR) pathway in the prefrontal cortex and hippocampus and 
led to rapid antidepressant-like behavioral effects in the forced swim test. 
Taken together, our findings highlight that Flx and isoflurane enhance 
synaptic plasticity in hippocampal and cortical excitatory synapses, however, 
the underlying molecular mechanisms as well as behavior improvements were 
different. In conclusion, the results described in this work provide a 
mechanistic background for adult brain plasticity and network tuning, with 
high practical significance to the design of clinical therapy.  
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1. REVIEW OF THE LITERATURE 
 
1.1 FEATURES OF NEURONAL TRANSMISSION 
 
Neurons in the mammalian brain communicate with each other mainly by 
using electrical and chemical signals, utilizing specialized compartments 
known as synapses. At electrical synapses, current flows through gap 
junctions, which are membrane channels that connect two cells. In contrast, 
chemical synapses enable communication via the secretion of specific 
molecules, neurotransmitters (NT), which are released into the synaptic cleft 
from the presynaptic terminal, triggered by an influx of calcium (Ca2+), usually 
as a consequence of an action potential (AP). NT bind to receptors at the 
postsynaptic membrane, which leads to depolarization (excitatory 
postsynaptic potential, EPSP) or hyperpolarization (inhibitory postsynaptic 
potentials, IPSP) of the target neuron and thus making them more or less 
likely to fire an AP. 
The major excitatory transmitter in the brain is glutamate, which exerts its 
postsynaptic actions via activation of both ionotropic (iGluRs) and G-protein-
coupled metabotropic (mGluRs) glutamate receptors (Scannevin & Huganir 
2000). Fast excitatory neurotransmission in the hippocampus is mediated by 
tetrameric glutamate-gated cation channels (iGluRs): N-methyl-D-aspartate 
(NMDA) receptors (GluNRs), a-amino-3-hydroxy-5-methyl-4-
isozazolepropionic acid (AMPA) receptors (GluARs) and kainate receptors 
(KARs) (Scheme 1). All glutamate receptors are mostly permeable to sodium 
(Na+) and potassium (K+), while NMDARs are also permeable to Ca2+. The 
Ca2+ permeability of other iGluRs depends on their subunit composition and 
mRNA editing. 
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Scheme 1. Classification of glutamate receptors 
 
Transmission efficacy and dynamics at glutamatergic synapses can easily be 
altered by ongoing neuronal activity in a process called synaptic plasticity. By 
virtue of this property, the glutamatergic synapse can thus act as a ‘cellular 
memory device’ containing information about the previous activity history of 
the neuronal circuitry (Malinow & Malenka 2002; Malenka & Bear 2004; 
Markram et al. 1997).  
Whilst glutamatergic synapses convey information in long projective neuronal 
pathways, GABAergic networks (operated mainly by gamma-aminobutyric 
acid (GABA)) control excitability and coordinate spatiotemporal integration 
properties of principal neurons. Inhibitory GABAergic transmission is 
mediated via ionotropic GABAA receptors (GABAARs) and metabotropic 
GABAB receptors (GABABRs). GABAARs are ion channels permeable to 
chloride (Cl-) and bicarbonate ions (HCO3-) and mediate both fast and tonic 
inhibition (Farrant & Nusser 2005; Capogna & Pearce 2011). Inhibitory 
GABAergic neurons (interneurons) perform several types of inhibition (Fig. 
1). In feedforward inhibition a principal cell and an interneuron receive 
excitatory inputs from the same presynaptic source (Sik et al. 1994). The 
interneuron then outputs its inhibitory signal to the principal cell. Thus, upon 
activation, the principal cell receives two types of input, one excitatory and 
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one inhibitory, separated by a brief delay due to interneuron integration. In 
the feedback mechanism, the principal cell receives excitatory input first and 
then outputs back to the interneuron (Anderen et al. 1964). Feed-back 
inhibition is mediated primarily by the perisomatic inhibition of pyramidal 
neurons. An extension of feedback inhibition is lateral inhibition (Freund & 
Buzsáki 1996). This occurs when the activation of a principal cell recruits an 
interneuron, which, in turn, suppresses the activity of surrounding principal 
cells. 
 
 
Figure 1. Types of inhibition in central nervous system. I-inhibitory neuron, P-principal 
cell. 
 
1.2  SYNAPTIC PLASTICITY 
 
In the brain, all neurons are structured in a complex system of neuronal 
networks. They consist of assemblies of excitatory and inhibitory neurons 
whose work is delicately synchronized and aimed at efficient processing of 
information coming from inside and outside of the brain. Effectiveness of 
information processing in the nervous system is very much dependent on the 
ability of the nervous system to reorganize its connections functionally and 
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structurally in response to changes in environmental experience, which is 
referred to as neuronal plasticity (Baroncelli et al. 2011).  
One of the most intriguing questions in neuroscience concerns the manner in 
which the nervous system can modify its organization and ultimately its 
function throughout lifetime. Synaptic plasticity for over a century has been 
proposed to play a central role in the capacity of the brain to incorporate 
transient experiences into persistent memory traces (Citri & Malenka 2008). 
Nowadays, many different forms of synaptic plasticity have been described; 
below the well-characterized plasticity principles will be elucidated. 
 
1.2.1   HEBBIAN SYNAPTIC PLASTICITY 
The plasticity rule proposed by Canadian psychologist Donald Hebb states 
that when one neuron drives the activity of another neuron, the connection 
between these neurons is potentiated (Hebb 1949). Nowadays, modifiable 
neuronal circuits are called “Hebbian” and the basic mechanism for synaptic 
plasticity, where an increase in synaptic efficacy arises from the presynaptic 
cell's repeated and persistent stimulation of the postsynaptic cell, is called 
“Hebbian plasticity” 
 
1.2.1.1   SHORT-TERM SYNAPTIC PLASTICITY 
Short-term plasticity (STP) refers to a phenomenon in which synaptic efficacy 
changes over time in a way that reflects the history of presynaptic activity. 
When two stimuli are delivered within a short interval, the response to the 
second stimulus can be either enhanced or depressed relative to the response 
to the first stimulus. If the second stimulus response is enhanced then the 
phenomenon is called paired pulse facilitation (PPF) and if depressed, paired 
pulse depression (PPD) (Katz & Miledi 1968; Zucker & Regehr 2002). Most 
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forms of STP are triggered by short bursts of activity causing a transient 
accumulation of Ca2+ in presynaptic nerve terminals. This increase in 
presynaptic calcium, in turn, causes changes in the probability of NT release 
(Pr) by directly modifying the biochemical processes that underlie the 
exocytosis of synaptic vesicles. 
Short term plasticity depends on the initial Pr. Synapses with a high initial Pr 
tend to depress, whereas those with a low initial probability of release usually 
facilitate. Indeed, most synapses can show either facilitation or depression 
depending on the initial Pr. Several models have been proposed to account for 
short-term plasticity, including summation of residual Ca2+ with repetitive 
stimulation, and local saturation of calcium buffers. It has also been suggested 
that short-term changes in synaptic function is associated with the specific 
release sensor (Zucker & Regehr 2002). 
Even if every synapse, examined in organisms ranging from invertebrates to 
mammals, exhibits numerous forms of short-term synaptic plasticity, the 
physiological meaning of STP still hasn’t been fully recognized (Zucker & 
Regehr 2002), however, a few assumptions exist. Short term synaptic 
plasticity in mammalian brain may serve as high and low-pass filters 
influencing on function of information processing. For example, synapses 
with a low initial Pr function as high-pass filters, since they will facilitate 
during high-frequency action potential bursts while low-frequency bursts will 
not be transmitted with the same efficacy. In contrast, synapses with a high 
initial Pr function as low-pass filters, since they will depress during high-
frequency bursts but will reliably relay low-frequency activity (Abbott & 
Regehr 2004). 
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1.2.1.2   LONG TERM SYNAPTIC PLASTICITY 
Approximately two decades after Hebb published his postulate, Terje Lømo 
and Tim Bliss in 1968 showed that high-frequency electrical stimulation in the 
dentate gyrus of the rabbit hippocampus cause persistent growth of response 
amplitude and called this phenomenon long term potentiation (LTP) (Bliss & 
Lomo 1973). Over the past 40 years, long-lasting synaptic enhancement has 
been an object of intense investigation because it has been proposed that long 
term potentiation provides an important key for understanding the cellular 
and molecular mechanisms by which memories are formed and stored. 
Investigation of the mechanism of this phenomenon forced the study of LTP 
into the field of synaptic plasticity, in particular to in vitro studies of living 
hippocampal slices.  
The hippocampal formation consists of different sections: subiculum, dentate 
gyrus (DG) and cornu ammonis (CA) and in rodents brain presented as folded 
structure of excitatory/principal and inhibitory/interneuron cells. The CA 
divides further into three different regions CA3, CA2 and CA1. A very 
important feature of the hippocampus is the relay organisation of synaptic 
transmission, the so called trisynaptic loop (Fig. 2), which starts in the 
entorhinal cortex where through granule cell fibers - perforant path - 
information is processed to DG. DG granule cells project to CA3 pyramidal 
cells synapses (mossy cell fibers). And then CA3 pyramidal cells form synapses 
on CA1 pyramidal cells, which cell bodies are organized in the thick band 
(striatum radiatum). Afferent fibers that connect CA3 and CA1 areas of 
hippocampus are called Schaffer collateral (SC). Pyramidal neurons in the CA1 
area then synapse in the subiculum and and project to the entorhinal cortex. 
Collectively the DG, CA3 and CA1 areas of the hippocampus compose the 
trisynaptic loop. 
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Figure 2. Schematic representation of the synaptic connectivity in the transverse 
hippocampal slice. Hippocampal trisynaptic loop consist of DG-CA3-CA1 synaptic 
pathways there entorhinal cortex-DG pathways called perforant fiber pathway, DG-CA3 - 
mossy fibers, CA3-CA1 – Shaffer collateral. 
 
The classical way to observe LTP is via tetanic stimulation and recording of 
field postsynaptic potentials (fEPSPs) in hippocampal slices. However, there 
are other protocols for LTP induction. For example, the coupling of low 
frequency presynaptic stimulation with postsynaptic depolarization is one 
effective method used to induce LTP that can last for several hours 
(Gustafsson & Wigström 1988; Liao et al. 1995; Chen et al. 1999). Theta burst 
stimulation is another method of LTP induction, resembling the physiological 
events underlying the LTP. It takes its name from the theta rhythm observed 
on electroencephalogram (about 5 Hz) in living hippocampus. For instance, 
10 trains consisting of 4 pulses at 100 Hz with 200 msec interval, effectively 
induces LTP in CA1 area of hippocampus (Larson et al. 1986; Staubli & Lynch 
1987). It is important to notice that LTP occurs not only at excitatory synapses 
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of the hippocampus, but at many other synapses in a variety of brain regions 
(Yaniv et al. 2000; Grossman et al. 2002; Berretta et al. 2008; Caruana et al. 
2012). Moreover, several properties of LTP match the properties of some 
forms of memory, suggesting that LTP may underlie cognitive functions. First, 
LTP is input-specific, which means that when it is generated in one synapse it 
doesn’t normally occur in another. LTP is associative - weak stimulation of a 
pathway will not by itself trigger LTP. However, if one pathway is weakly 
activated at the same time that a neighboring pathway onto the same cell is 
strongly activated, both synaptic pathways undergo LTP. Although LTP is 
triggered rapidly, it last for hours in vitro and days in vivo and the late phase 
of LTP requires gene transcription and protein synthesis. Clearly, LTP reflects 
a mechanism that most likely contributes to memory formation by triggering 
long lasting, perhaps permanent changes in neuronal circuitry. 
NMDA-dependent long term potentiation 
In the CA1 region of hippocampus, as well as many other areas of the central 
nervous system (CNS), LTP induction requires a rise in postsynaptic Ca2+ via 
activation of NMDA receptors (Fig. 3). In order for the NMDA receptor 
channel to conduct, glutamate must bind to the receptor and the postsynaptic 
membrane must be depolarized. The basis for this is a voltage-dependent 
block of the ion channel by extracellular magnesium (Mg2+). However when 
the postsynaptic cell is depolarized during induction of LTP, Mg2+ dissociates 
from its binding site within the NMDA receptor channel, allowing Ca2+ as well 
as Na+ to enter. It is now well accepted that trafficking of other glutamate 
receptors (AMPA receptors) to and away from synaptic plasma membrane 
plays an essential role in LTP induction, expression and maintenance. AMPA 
receptors are composed of four types of subunits GluA (1-4). Most AMPA 
receptors are heteromeric, consisting of symmetric 'dimer of dimers' 
complexes of GluA2 and either GluA1, GluA3 or GluA4 and, depending on 
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subunit composition of receptor; they may play distinct roles in neural 
communication. There are two general models explaining how the synapses 
acquire AMPA receptors during LTP. In the first model, glutamate receptors 
are freely moving via lateral diffusion into and out of the synapse (Opazo et al. 
2012). In the second model, neuronal activity triggers exocytosis, which leads 
to insertion of GluARs into the synapse from an intracellular pool (Park et al. 
2004). There are strong evidential data supporting both models, however 
further experiments are needed to clarify this issue. 
 
Figure 3. Schematic representation of NMDA-dependent LTP. Robust stimulation of 
presynaptic terminal (or other protocols of stimulation) causes release of glutamate and 
consequent activation of AMPA and NMDA receptors. Depolarization induced CA2+ enter 
results in activation of downstream signaling molecules, transcription factors and 
internalization of AMPA receptors. 
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Activation of AMPA and NMDA receptors, except NMDA-independent forms, 
seems essential for the induction of long term synaptic plasticity, but 
insufficient to elicit a stable form of LTP. Calcium/calmodulin dependent 
protein kinase II (CaMKII) is essential as a mediator for NMDA-dependent 
LTP. CaMKII is found in high concentrations in the postsynaptic density: the 
postsynaptic component of the dendritic spine that also contains glutamate 
receptors. Loading of cells with a constitutively active form of CaMKII 
enhances EPSCs, whereas genetic deletion of a critical CaMKII subunit blocks 
the ability to generate LTP (Gustafsson & Wigström 1988; Malenka et al. 
1989). Several other protein kinases, including protein kinase C (PKC), cyclic 
adenosine-monophosphate (cAMP)–dependent protein kinase (PKA), the 
tyrosine kinase Src, and mitogen-activated protein kinase (MAPK), have also 
been suggested to contribute to LTP (Teyler & DiScenna 1987; Gustafsson & 
Wigström 1988; Larkman & Jack 1995; Wikström et al. 2003). 
Neurotrophins, specifically brain derived neurotrophic factor (BDNF), are of 
particular interest to synaptic plasticity because of the possibility that BDNF 
may serve as a mediator rather than simply as a modulator of LTP. The idea 
that BDNF might be involved in synaptic plasticity came from the observation 
that the expression of BDNF in the hippocampus can be induced by high 
frequency stimulation and that endogenous BDNF is required for LTP 
induction in hippocampal CA1 pyramidal neurons (Castrén et al. 1993; 
Patterson et al. 1996). Importantly, BDNF acts on synaptic transmission from 
both pre and post synaptic sites. Presynaptically, BDNF enhances glutamate 
release and increases the frequency of miniature EPSCs (mEPSCs) in 
hippocampus (Takei et al. 1998; Lessmann & Heumann 1998; Waterhouse & 
Xu 2009). On the postsynaptic site, BDNF increases NMDA single-channel 
open probability (Levine et al. 1998; Levine & Kolb 2000) presumably through 
tyrosine phosphorylation of the NMDA receptor subunits (Suen et al. 1997; 
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Lin et al. 1998) and regulate its expression by transcription dependent 
mechanisms (Caldeira et al. 2007; Carvalho et al. 2008). 
The later stages of LTP are dependent upon both protein translation and gene 
transcription, which similarly involves the participation of multiple signaling 
pathways. During LTP, protein synthesis is required to supply functional and 
structural changes. In this regard, the mammalian target of rapamycin 
(mTOR) pathway was found to be important for LTP expression (Tang et al. 
2001). mTOR is known to regulate both dendritic and somatic protein 
synthesis in neurons (Hoeffer & Klann 2010). Examples of mTOR translation 
targets include CaMKII, PSD-95 and GluR1 (Slipczuk et al. 2009). Another 
well studied transcription factor involved in LTP is cAMP response element-
binding protein (CREB) (Bengtson & Bading 2012). CREB targets genes 
including Bdnf and its cognate receptor tropomyosin receptor kinase B (TrkB) 
(Deogracias et al. 2004), Wnt2 (Wayman et al. 2006) and different glutamate 
receptor subunits (Wayman et al. 2006; Traynelis et al. 2010). 
NMDA- nondependent long term potentiation 
In most of the synapses, LTP requires the activation of NMDA receptors which 
are generally considered to be expressed postsynaptically. However, there are 
regions in the brain which undergo long term synaptic plasticity but the origin 
and basis of synaptic strengthening in those synapses are fundamentally 
different. Synaptic transmission and plasticity at the hippocampal mossy fiber 
synapse is unusual for several reasons, including low basal Pr, pronounced 
frequency facilitation and a lack of NMDARs involvement in LTP. 
Experimental evidence suggest that mossy fiber LTP does not need any 
postsynaptic activation but is triggered by an activity-dependent increase of 
Ca2+ in the presynaptic terminal (Katsuki et al. 1991; Maccaferri et al. 1998). 
Another set of findings suggest an important role of presynaptic kainate 
receptors in induction and maintenance of mossy fiber LTP. Thus, application 
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of a selective kainate receptor antagonist, which did not affect mossy fibre 
synaptic transmission, completely blocks the induction of mossy fibre LTP in 
a fully reversible manner (Bortolotto et al. 1999). Additionally, kainate 
receptors are found in higher levels in the CA3 region of the hippocampus.  
Another non-conventional example of NMDA-independent form of long term 
synaptic plasticity is LTP in glycinergic synapses. Glycine receptors (GlyRs) 
are structurally related to GABAARs and have a similar inhibitory role. In the 
superficial dorsal horn of the spinal cord, glycinergic synapses on inhibitory 
GABAergic neurons exhibit LTP (GlyRs LTP), which occurs rapidly after 
exposure to the inflammatory cytokine interleukin-1 beta. Notably, formalin-
induced peripheral inflammation in vivo potentiates glycinergic synapses on 
dorsal horn neurons, suggesting that GlyR LTP is triggered during 
inflammatory peripheral injury (Chirila et al. 2014) 
 
1.2.1.3   SPIKE TIMING DEPENDENT PLASTICITY 
Another form of Hebbian long-term synaptic plasticity, spike-timing-
dependent plasticity (STDP), depends on the relative timing of pre- and 
postsynaptic action potentials. A pioneering study by W. Levy and O. Steward 
(1983) demonstrated that stimulation of inputs from entorhinal cortex to the 
DG produced potentiation when the weak input preceded the strong input by 
less than 20 ms, and reversing the order led to depression (Levy & Steward 
1983). Later on H. Markram and colleagues (1997), controlling pre- and 
postsynaptic spike timing, discovered that order and timing of pre- and 
postsynaptic spikes was critical for direction and magnitude of postsynaptic 
response (Markram et al. 1997) Although STDP describes new synaptic 
plasticity principles in neuronal network, the mechanisms underlying this 
phenomenon seems to be allied to classical Hebbian synaptic plasticity.  
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1.2.2  HOMEOSTATIC SYNAPTIC PLASTICITY 
Homeostatic synaptic plasticity is a form of synaptic plasticity that acts to 
stabilize the activity of a neuron or neuronal circuit in the face of perturbations 
and complements Hebbian forms of plasticity where activity-dependent 
refinement of synaptic connectivity occurs. One of the most studied forms of 
homeostatic plasticity is synaptic scaling. In pioneering experiments by G. 
Turrigiano and colleagues (Turrigiano et al. 1998), it was demonstrated that 
chronic blockade of cortical culture activity increased the amplitude of 
miniature EPSCs (mEPSCs) without changing their kinetics. Conversely, 
blocking GABA - mediated inhibition initially raised firing rates, but over a 
48-hour period mESPC amplitude decreased and firing rates reconciled to 
control values. This study demonstrates that, at least in vitro, homeostatic 
plasticity mechanisms are in place that function to keep activity relatively 
constant in the face of even major perturbations.  
The major expression mechanism underlying homeostatic plasticity is 
through bidirectional accumulation of AMPA receptors. In spinal and 
neocortical neurons there are proportional changes in GluA1 and GluA2 
subunits of AMPA receptors, after tetrodotoxin (TTX) blockade of neuronal 
activities (O’Brien et al. 1998; Wierenga et al. 2005), where studies on 
hippocampal neurons have reported enhanced GluA1 accumulation with 
smaller or absent changes in GluA2 (Thiagarajan et al. 2005; Sutton et al. 
2006). Several studies have demonstrated the role of BDNF in synaptic 
scaling. BDNF is thought to be released by cortical pyramidal neurons in an 
activity dependent manner, and exogenous BDNF can prevent the effects of 
activity deprivation. Further, preventing activation of endogenous BDNF 
receptors mimics the effects of activity blockade (Rutherford et al. 1998; Copi 
et al. 2005). Evidently, there are likely multiple forms of synaptic homeostasis, 
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mediated by distinct signalling pathways and with distinct expression 
mechanisms (Ramakers et al. 1990; Corner & Ramakers 1992; Rutherford et 
al. 1998; Trasande & Ramirez 2007). And since the field of homeostatic 
synaptic plasticity is still relatively young it is expected that the cast of 
molecular players thought to be involved will rapidly accumulate over the 
time. Altogether, homeostatic synaptic plasticity serves as mechanisms to 
stabilize firing rates in the face of developmental or learning-induced changes 
in drive, and this contributes to the ability of central neuronal networks to 
maintain stable function and enables networks to maintain the specificity of 
synaptic changes that encode information. 
 
1.3 NEURONAL PLASTICITY 
 
1.3.1  TIMELINE OF PLASTICITY 
Major challenges for the field of synaptic plasticity now include understanding 
when and why different forms of plasticity are present in real neuronal 
networks, and how these mechanisms interact with each other to generate 
flexible yet stable brain function.  
Even though plasticity is an obvious phenomena in the brain, it is not present 
constantly throughout lifetime (scheme 2). During prenatal development and 
short time after a birth it is impractical for the genome to specify the 
connectivity of every connection in the brain. Later, connections are sculpted 
in response to internal and external events. During maturational stages in the 
lifespan of an organism nervous system is especially sensitive to certain 
environmental stimuli and these periods, which are called critical periods, are 
characterized with heightened plasticity. In the early 1960s David H. Hubel 
and Torsten Wiesel clearly demonstrated that sensory experience shapes 
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neuronal networks and that the degree to which the brain is changed by 
experience is variable and age dependent (Wiesel & Hubel 1963).  
In primates and cats, visual inputs from each eye segregate into eye-specific 
regions in the primary visual cortex, called ocular dominance columns, where 
most of the neurons in columns are activated to some degree by both eyes, and 
about a quarter are more activated by either the contralateral or ipsilateral eye 
(Hubel & Wiesel 1963; Blakemore & Vital-Durand 1986). This segregation 
process takes place during a critical period of early postnatal development and 
requires the balanced use of both eyes (Wiesel 1982). However, if one eye is 
closed during the critical period, very few cells could be driven from the 
deprived eye and ocular dominance distribution is shifted such that all cells 
are driven by the eye that remained open. Such changes lead to development 
of poor vision or amblyopia. Importantly, if the patch is removed during the 
critical period and the use of the weaker eye is encouraged by patching the 
better eye, the vision of the amblyopic eye can be recovered. However, after 
the closure of this critical period, amblyopia becomes permanent and cannot 
be revised by patching of the better eye (Hubel & Wiesel 1963; Wiesel & Hubel 
1965). Nowadays, it is widely accepted that similar processes govern the 
development and tuning of neuronal networks not only in visual system but 
in other brain regions. During normal development sensitive periods for the 
elaboration of sensory pathways (vision, hearing) and higher cognitive 
function elapse in humans to around 7 years of age and in rodents to day 21 of 
postnatal development. Important, timing of critical periods for different 
systems may significantly vary (Hensch 2003). 
Use-dependent plasticity, plasticity which is sensitive to experience, continues 
to take place in adulthood. Adult brain plasticity is much more restricted in 
scope but still possible. Normal or naïve adult brain plasticity underlies our 
ability to form memories, learn and cope with changing environment (Kolb et 
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al. 2003; Robinson & Kolb 2004). Recent studies have shown, using 
mammalian visual cortex as an experimental model (Hensch 2005), that it is 
possible to reinstate much greater levels of plasticity in the adult visual cortex 
than previously suspected, employing various environmental and 
pharmacological strategies (Sale et al. 2007; Hensch 2003; Hensch 2005). 
This type of plasticity does not present in normal adult brain but can be 
induced by various interventions. It characterized with features similar to 
critical periods and thus is usually called reopened critical period or juvenile-
like plasticity. We propose to use the term iPlasticity, which means induced 
plasticity, to describe structural and functional reorganizations of mature 
neuronal networks stimulated by intense environmental or/and 
pharmacological influence. 
Scheme 2. Timeline of plasticity. 
 
 
1.3.2  TOOLS TO TRIGGER IPLASTICITY 
 
1.3.2.1   ENVIRONMENTAL ENRICHMENT 
Exposure to complex environment, rich with sensory stimuli, so-called 
environmental enrichment (EE) – has been shown to induce plasticity. In 
neuroscience, EE refers to housing conditions of laboratory animals, where a 
combination of complex inanimate and social stimulation facilitates sensory, 
cognitive and motor function (Rozenzwieg et al. 1962). Enriched animals are 
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reared in large groups and maintained for at least three weeks in an 
environment where a variety of objects (e.g. toys, tunnels, nesting material 
and stairs) are present and change frequently. 
It was demonstrated that EE restores plasticity of the visual cortex in 
adulthood (Sale et al., 2007).Exposure of adult rats to EE completely rescued 
the visual deficits associated with amblyopia (Sale et al., 2007). Consistent 
with this finding, it has been demonstrated that EE affected structural 
plasticity: increased dendritic branching and length, the number of dendritic 
spines, the size of synapses on some neuronal populations (Rosenzweig et al. 
1964; Beaulieu & Colonnier 1987; Greenough et al. 1987) and synaptic 
plasticity: increased basal synaptic transmission and long term potentiation 
in hippocampus (Foster et al. 1996). At the level of behavior, environmental 
complexity enhanced learning and memory (Moser et al. 1997; Rampon et al. 
2000; Tang et al. 2001; Lee et al. 2003), reduced memory decline in aged 
animals (Bennett et al. 2006), decreased anxiety and increased exploratory 
activity (Chapillon et al. 1999; Friske & Gammie 2005). Clearly, exposure to 
EE reinstates critical period plasticity and can be used as a tool to study 
iPlasticity. 
 
1.3.2.2   FLUOXETINE 
Fluoxetine (Flx, also known as Prozac) is an antidepressant of the selective 
serotonin reuptake inhibitor (SSRI) class, which was discovered and 
developed by scientists from Eli Lilly and Company in 1974 (Wong et al. 1974). 
It is frequently used to treat major depressive disorder, obsessive-compulsive 
disorder, post-traumatic stress disorder, bulimia nervosa, panic disorder, 
premenstrual dysphoric disorder, trichotillomania etc. For a long time it was 
thought that mechanism of Flx action on the nervous system was associated 
with increasing serotonin levels by serotonin uptake blockade, which was very 
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much in line with the action of other antidepressants on monoamines balance 
in the brain. At the time it formed the basis for the monoamine theory of 
depression, which proposed that this condition was caused by a deficiency in 
monoaminergic neuromodulators and antidepressant drugs acted by 
replenishing them (Schildkraut 1995). 
Recent studies showed that chronic treatment with Flx induced a plastic state 
in the visual cortex which closely resembles that observed at the peak of the 
critical period (Maya Vetencourt et al. 2008). When adult rats were treated 
with Flx, closing of one eye produced a dramatic shift in the sensitivity of 
visual cortical neurons in favor of the open eye, a response normally seen only 
during the early postnatal critical period (Maya Vetencourt et al., 2008). 
Furthermore, visual acuity of the amblyopic eye could be fully restored in 
adulthood when the eye was opened during Flx treatment and the previously 
open eye was simultaneously closed to encourage the use of the weak eye 
(Maya Vetencourt et al. 2008). Flx induced neuronal network changes that 
were also associated with reduced inhibition and enhanced expression of 
BDNF and TrkB (Saarelainen et al. 2003; Rantamäki et al. 2007; Maya 
Vetencourt et al. 2008). Importantly, only long term Flx administration 
enhances neuronal plasticity (Wang et al. 2008). Together these findings 
suggest that Flx action on neuronal networks may differ from its conventional 
role as an AD and may be associated with iPlasticity.  
 
1.3.2.3   KETAMINE AND ISOFLURANE 
Isoflurane is a halogenated ether used for inhalational anesthesia. Its use in 
human medicine is now starting to decline, however it is still frequently used 
for veterinary anesthesia. A pioneering study by Langer and colleagues (1985) 
revealed a rapid antidepressant effect of isoflurane on depressed patients 
(Langer et al. 1985). In their study treatment-resistant depressed patients who 
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primarily have been subjected to electroconvulsive therapy (ECT) were given 
a series of anesthesias with isoflurane and then tested for symptoms of 
depression. The authors hypothesized that a brief period of electrocerebral 
silence, which can be observed shortly after the grand mal seizure in ECT, may 
be, in itself, a crucial for the therapeutic effects of ECT. In this study, they 
clearly demonstrated rapid relief in depressive symptoms after isoflurane 
administration, which persist for several weeks. A study with another 
anesthetic, ketamine, in a placebo-controlled, double-blinded trial in humans 
demonstrated that a single ketamine administration significantly improves 
depressive symptoms within 72 hours after drug infusion (Berman et al. 
2000).  
While the mechanisms underlying isoflurane and ketamine rapid 
antidepressant action remain unclear, several lines of evidence suggest that 
treatment with ketamine also depends on plasticity. Thus ketamine produces 
a rapid antidepressant-like behavioral response in rodents subjected to 
chronic stress (Maeng et al. 2008; Li et al. 2010; Autry et al. 2011). However, 
because of its psychotomimetic properties, clinical use of ketamine is limited 
by abuse potentials (Machado-Vieira et al. 2009) and the lack of clinical 
studies of isoflurane action means it is currently not allowed to replace 
conventional ADs with fast acting anesthetics, but it is evidently possible to 
use these chemicals to study iPlasticity. 
 
1.3.3  FEATURES OF IPLASTICITY 
 
1.3.3.1   ROLE OF BDNF AND TRKB 
The first member of the neurotrophin family, nerve growth factor (NGF) 
(Cohen & Levi-Montalcini 1956), was discovered in the early 1950s as a target-
derived protein that promotes the survival and growth of sympathetic and 
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sensory neurons during development. The establishment of the neurotrophins 
family came with the purification and characterization of BDNF from pig 
brain by H. Thoenen laboratory (Barde et al. 1982). Since then, two other 
neurotrophins have been identified in the mammalian brain: neurotrophin 3 
and 4 (NT3, NT4) (Lewin & Barde 1996). Neurotrophins are small proteins 
(molecular weight about 13 kDa) and like other secreted proteins, arise from 
precursors, proneurotrophins (30–35 kDa), which are proteolytically cleaved 
to produce mature proteins. Several studies showed that trophic factors are 
secreted in both mature (cleaved) and immature (non cleaved) forms (Mowla 
et al. 1999; Zhou et al. 2004). Two types of receptors for neurotrophins have 
been identified: p75NTR (Reichardt 2006), which belongs to the family of 
tumor necrosis factor (TNF) receptors and binds proneurotrophins; and one 
of the three tropomyosin-related kinase (Trk) receptors — NGF binds to 
TRKA, BDNF and NT4 bind to TRKB, and NT3 binds to TRKC. Through the 
differential expression and cellular localization of their receptors, 
neurotrophins can elicit diverse cellular responses in different types of 
neurons and at different cellular loci (Chao 2003; Reichardt 2006). But in 
general, interaction of mature trophic factors with Trk receptors leads to cell 
survival, whereas binding of neurotrophins precursors (proNGF and 
proBDNF) to p75NTR leads to apoptosis (Reichardt 2006; Chao 2003).  
A solid body of data firmly established the role of BDNF and TrkB signaling in 
iPlasticity. Original observations from Ronald Dumans laboratory 
demonstrated that different classes of ADs significantly increased the 
expression of BDNF in the major subfields of the hippocampus (Nibuya et al. 
1995). ADs have also been shown to increase BDNF protein levels not only in 
the hippocampus but in other brain regions (Altar et al. 2003; Calabrese et al. 
2007; Balu et al. 2008; Maya Vetencourt et al. 2008). Phosphorylation of 
TrkB receptors have been also associated with iPlasticity. Different chemical 
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classes of ADs increased TrkB phosphorylation, resulted in an associated rise 
in phospholipase γ (PLCγ) and CREB acutely (within 30 min) and persist for 
at least 3 week of continuous treatment (Saarelainen et al. 2003; Rantamäki 
et al. 2007). Interestingly, it was found that increased TrkB phosphorylation 
by ADs is independent of BDNF (Rantamäki et al. 2011) and behavior effects 
induced by ADs are blunted in mice with reduced level of BDNF and inhibited 
TrkB signaling (Saarelainen et al. 2003; Guiard et al. 2007; Deltheil et al. 
2008; Li et al. 2008). 
 
1.3.3.2   ROLE OF EXTRACELLULAR MATRIX  
Chondroitin sulfate proteoglycans (CSPGs) are components of the 
extracellular matrix (ECM) that inhibit axonal sprouting and growth. Their 
adult pattern of expression is very high. CSPGs condense around the soma and 
dendrites of a subset of neurons in the form of perineuronal nets (PNNs) 
(Köppe et al. 1997). The absence of PNNs is considered to be a key permissive 
factor that allows the induction of ocular dominance plasticity during the 
critical period (Pizzorusso et al. 2002a). The assembly of PNNs around 
parvalbumin (PV)-expressing inhibitory interneurons is thought to contribute 
to critical-period closure (Pizzorusso et al. 2002). PNNs preferentially 
surround cell bodies and proximal neurites of mature fast spiking PV-positive 
interneurons, which was suggested to limit PV cell plasticity by controlling the 
concentration of extracellular ions that surround these cells or by sequestering 
molecular factors which regulate plasticity (Härtig et al. 2001; Hensch 2003; 
Inoue et al. 2007). Consistent with this notion, the degradation of PNNs with 
chondroitinease ABC in adults allow the induction of ocular dominance 
plasticity in visual cortex (Pizzorusso et al. 2002a; Gogolla et al. 2009). 
Altogether, it is possible to conclude that iPlasticity is associated with 
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modified extracellular environment which is primarily, in the adult brain, 
directed to stabilize neuronal connections. 
 
1.3.3.3   DISINHIBITION AS A MECHANISM OF IPLASTICITY 
Inhibition plays a crucial role in shaping neuronal networks in response to 
changing environment. As it was described previously, the ocular dominance 
shift induced by Flx and EE was associated with an altered intracortical 
inhibitory-excitatory balance due to reduced GABAergic inhibition - 
disinhibition. Sale and co-authors revealed that three weeks exposure of 
amblyopic rats to EE promoted a complete recovery of both visual acuity and 
ocular dominance and this striking effect was associated with a threefold 
reduction in the basal level of GABA detected by in vivo brain microdialysis in 
the visual cortex (Sale et al. 2007). Reduced cortical inhibition was also found 
in synaptic plasticity levels, since the visual cortical slices of EE animals 
displayed full reinstatement of white matter-LTP, a phenomenon that is 
usually absent in the adults (Artola & Singer 1987; Sale et al. 2007; Maya 
Vetencourt et al. 2008). Moreover local and transient suppression of 
inhibition in adult brain restore critical period-like plasticity and promote 
ocular dominance plasticity in adult brain (Hensch 2003; Harauzov et al. 
2010).  
Recent studies elucidated the role of PV-positive inhibitory cells in 
mechanisms underlying iPlasticity. It was proposed that a transient 
suppression of PV cells may gate cortical plasticity. Mimicking a transient (24 
h) reduction of inhibition upon eyelid suture by selective activation of 
designed receptors exclusively activated by designed drugs (DREADDs) 
within PV cells enables plasticity beyond the critical period (Kuhlman et al. 
2013). Another study revealed that chronic Flx administration lead to reduced 
GABA release from PV positive basket cells (Méndez et al. 2012). All together, 
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these findings clearly demonstrate an important role of neuronal networks 
disinhibition as a mechanism of iPlasticity where PV positive inhibitory cells 
are a central hub.  
 
1.3.3.4   ROLE OF NEUROGENESIS 
The environment has a striking influence on the rate of adult neurogenesis 
(Kempermann et al. 1997; Young et al. 1999; Uda et al. 2006). The iPlasticity 
has been associated with reinforced neurogenesis in DG. Chronic treatment 
with Flx and exposure to complex environment enhance neurogenesis and 
affect the maturation and functional integration of newborn neurons into 
hippocampal networks (Malberg et al. 2000; Olson et al. 2006; Kobayashi et 
al. 2010; Klomp et al. 2014). Flx induced plasticity enhances neurogenesis-
dependent LTP in the DG and ablation of neurogenesis with x-irradiation 
completely block the effects of chronic Flx on synaptic function (Wang et al. 
2008). Interestingly, it was also demonstrated that disruption of Flx-induced 
neurogenesis blocks behavioral responses to antidepressants (Santarelli 
2003).  
 
1.3.3.5   IPLASTICITY AND BEHAVIOR 
Changes in the structural and functional properties of the brain reflect 
changes in behavior. Thus, enhanced neuronal plasticity not only improves 
learning and memory (Rampon et al. 2000; Lee et al. 2003; Bennett et al. 
2006), reduces memory decline in aged animals, decreases anxiety-like 
behavior and increases exploratory activity (Chapillon et al. 1999; Friske & 
Gammie 2005), but also leads to better recovery following diverse 
pathological conditions. In order to study iPlasticity and behavior, a few 
common stress based models of depression-like behavior can be used. 
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The forced swim test (FST) is a model of “behavioral despair” used to study 
depression-like and antidepressant-like behavioral responses in rodents 
(Slattery & Cryan 2012). In FST, after the placement of rodents to beaker with 
water, despair behavior is analyzed as proportion of active response to 
immobility, where more animal spends in immobile state versus active the 
more depression it express. The novelty suppressed feeding (NSF) test can be 
used to measures anxiety-like behavior and study response to antidepressant 
treatment (Bodnoff et al. 1988; Santarelli 2003). In this paradigm latency to 
eat, for a food deprived animals, which were obliged to move into bright area 
in open field , is considered as anxiety-related behavior, and chronic, but not 
acute, antidepressant administration decreases the latency (Bodnoff et al. 
1988; Santarelli 2003). 
Another behavior paradigm, which can be implemented to study plasticity, is 
fear conditioning (FC) (Pavlov I, 1927). It recruits ability of animals to learn 
by experience that some stimuli precede danger. This in turn leads to 
formation of a life-long memory, which has made Pavlovian fear conditioning 
such a widely used and most intensively studied paradigm in translational 
neuroscience (Milad & Quirk 2012). In animal models, FC is mainly 
recognized as an associative learning task in which an aversive stimulus 
(unconditioned stimulus, US) is paired with a particular neutral context or 
stimulus (conditional stimulus, CS) resulting in the expression of fear 
responses to the originally neutral stimulus or context. During fear 
acquisition, the neutral stimulus alone starts to elicit the fear reaction, which 
can be measured as a freezing of an experimental animal. If the animal is after 
successful acquisition is repeatedly exposed to the CS alone without the US, 
freezing response gradually decreases, a process known as fear extinction 
(Milad & Quirk 2012). Extinction is regarded as a new type of learning in 
which extinction networks inhibit fear networks (Myers & Davis 2007). 
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However, extinction learning is not very effective: freezing response typically 
reappears after a few days (known as spontaneous recovery), especially if the 
animal is exposed to the environment where the pairing between the US and 
CS took place (fear renewal) (Milad & Quirk 2012). 
It is important to recognize that fear memories do not reside in a single 
anatomical locus but rather arise from interactions among a number of 
structures that compose a neural circuit. Anatomical, behavioral and 
electrophysiological evidence indicates that complex networks are involved in 
learning and expressing fear responses. These include, but are not limited to, 
the amygdala, the medial prefrontal cortex (mPFC) and the hippocampus 
(Duvarci & Pare 2014). The amygdala nuclei involved in fear learning can be 
divided into two main sub-areas that fundamentally differ in their anatomical 
and functional organization: the basolateral complex and the central 
amygdala. The basolateral complex consist of approximately 80% of 
glutamatergic spiny projection neurons and 20% GABAergic neurons and 
receives inputs from both subcortical and cortical sensory regions including 
thalamus, cortex and hippocampus (McDonald 1998; Swanson & Petrovich 
1998). By contrast, the central amygdala is mainly composed of GABAergic 
neurons, many of which project to brain areas that are important for 
mediating defensive behaviors (Swanson & Petrovich 1998; Sah et al. 2003). 
Emerging literature suggests a role for the hippocampus and mPFC in the 
regulation of fear memories. It was demonstrated that ventral (infralimbic, 
IL) and dorsal (prelimbic, PL) mPFC play opposing roles in fear (Ji & 
Neugebauer 2012; Do-Monte et al. 2015). For example, activation of 
projections from the IL to the basomedial amygdala with channelrhodopsin-
2 and light decreases the anxiety and promotes fear extinction (Adhikari et al. 
2015). In contrast, activation of the PL increases fear responses and impairs 
extinction (Vidal-Gonzalez et al.). Finally, hippocampus has been shown to be 
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involved in indexing those associations to the contexts in which they occurred. 
Ventral hippocampus projects both to the mPFC and the basolateral amygdala 
and, depending on the experimental condition, may either enhance or inhibit 
fear extinction (Milad & Quirk 2012). For example, pharmacological 
inactivation of the ventral hippocampus prevents context-dependent fear 
renewal and interferes with context-dependent changes in extinction (Sparta 
et al. 2014).  
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2. AIMS OF STUDY 
 
The major aim of this thesis was to advance our understanding of the 
mechanisms associated with plasticity induced in the adult brain. More 
specifically, the aims were: 
 
1. To study Flx iPlasticity in pathology via examination of behavior and 
structural changes associated with Flx treatment after exposure to fear. 
 
2. To study the mechanisms of iPlasticity in naïve mice induced by 
chronic Flx administration and single exposure to isoflurane. 
 
3. To study hippocampal synaptic plasticity underlying long term Flx 
administration and single isoflurane exposure. 
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3. MATERIALS AND METHODS 
 
3.1  EXPERIMENTAL ANIMALS 
Adult male mice C57Bl/6JRcc.Hsd (Harlan, Netherlands) at 8-16 weeks old 
age were housed individually or in groups. Animals were kept under 12 h 
light/dark cycle (light on at 6 am). Food and water were available ad libitum. 
All animal procedures were done according to Animal Ethical Committee of 
Southern Finland and covered by ESAVI/7551/04.10.07/2013 license. 
 
3.2  DRUG TREATMENT 
Fluoxetine (study I, II, III) 
Mice received Flx (Orion Pharma, Helsinki, Finland) via drinking water in 
light-protected tubes. Solutions were prepared fresh every day. Flx was 
dissolved in tap water at concentration of 0.08 or 0.016 mg/ml to achieve 
approximately 10-20 mg/kg per day dosing unless otherwise stated. The 
treatment was continued through all behavioral sessions until sacrifice (study 
I) or continued until the final day of experiments (study III). 
Isoflurane (study IV) 
Isoflurane (Vetflurane, Virbac) treatment was induced in a chamber with 4% 
isoflurane for 2 minutes, after which the mouse freely inhaled isoflurane via a 
mask (3.0 % for 1 min, then 2 % for maximum 30 minutes; airflow: 0.3-0.5 
l/min). Body temperature was maintained by a heat pad throughout the 
treatment. Sham mice were kept in the induction chamber for 2 minutes 
without isoflurane.  
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3.3  BEHAVIOR 
Marble burying (study III) 
On day 20-21 of Flx or vehicle treatment mice were subjected to the marble 
burying test adapted from K. Njung’E and S. Handley (1991). Animals were 
placed individually into test cages (21×38×14cm) with 5 cm height of bedding. 
Twelve small marbles (15 mm diameter) were arranged on bedding in the form 
of an array. Mice were then exposed to marbles individually for 30 min and 
unburied marbles were counted. A marble was considered to be ‘buried’ if it 
was covered with bedding material more than 67% (i.e. two-third size). 
Behavior was then rated by counting the number of marbles buried and data 
was presented as % of buried marbles to control (before treatment) level. 
Fear conditioning and extinction (study I, II) 
Fear conditioning took place in context A (a transparent Plexiglas chamber 
with metal grids that was cleaned before each session with 70% ethanol). 
Freezing behavior was measured with an automatic infrared beam detection 
system which was placed on the sides of the fear conditioning chamber (TSE 
Systems GmbH, Germany). The mouse was considered to be frozen only if it 
was not moving for at least 3s, and this measure was expressed as percentage 
of time spent freezing. Every mouse was handled in the experimental room for 
5–10 min during each of the 3 days prior to fear conditioning. On the day of 
acquisition, mice were exposed to context A for 2 min and conditioned using 
5 pairings of the CS (Conditioned Stimulus; total duration 30s, 1Hz, white 
noise, 80dB) with the US (Unconditioned Stimulus; 1sf foot-shock 0.6mA, 
inter-trial interval: 20–120 s). The US was co-terminated with the CS. The 
freezing level during the first CS, preceding the first US, was taken as the 
baseline freezing during CS. Mice were then divided into four groups (two 
extinction (water and Flx drinking) and two no-extinction (water and Flx 
drinking) groups) with equal levels of freezing, two receiving Flx in their 
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drinking water until the end of the experiment and the other two receiving tap 
water. For the control group CTRL, mice were subjected to the same fear 
conditioning experimental protocol except that the CS was not followed by the 
US (non-conditioned, only context+ CS exposure group); then, the CTRL mice 
received tap water. Two weeks after the fear conditioning day, the mice from 
the CTRL and both no-extinction groups (n=6 per group) were sacrificed for 
subsequent immunohistochemical analysis. Fear extinction training, 
spontaneous recovery and fear renewal Two-day fear extinction training took 
place 2 weeks after fear conditioning in the context B (a black non-transparent 
Plexiglas chamber with a planar floor that was leaned before each session with 
70% 2-propanol). Freezing behavior was measured as described above. On the 
first and second extinction days, conditioned mice received 12 presentations 
of the CS (total duration 30s, 1 Hz, white noise, 80dB, inter-trial interval: 20–
60 s). One week after extinction, extinguished mice (n=6 per group) were 
sacrificed for subsequent immunohistochemical analysis. In parallel, 
additional mice (n=25 per each extinction group) were tested 7 days after 
extinction in context B and context A, respectively, using 4 presentations of 
the CS (inter-trial interval: 20–60 s) and were further used for Pearson's 
correlation analysis of context-dependent spontaneous recovery and fear 
renewal. 
3.4  LENTIVIRUS PRODUCTION (STUDY I) 
Time-specific BDNF overexpression in the basolateral amygdala was achieved 
using injection of lentivirus regulatable by doxycycline Tet-off system (33). To 
produce viral particles, the vector plasmid pTK431-BDNF, the packaging 
plasmid p∆NR and the envelope plasmid pMDG-VSV-G (ratio 4:3:1) were 
cotransfected into HEK293T cells as described previously (33). The viral 
particles were collected by ultracentrifugation and resuspended in MEM. 
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Virus titer was determined using p24 antigen ELISA as 0.21 mg/ml of p24 and 
viral solution was kept at -80°C in small aliquots.  
3.5  STEREOTACTIC INJECTIONS (STUDY I) 
Pilot experiments were performed to determine the stereotaxic coordinates of 
the basolateral amygdala: bregma -1.7, lateral ±3.6 and ventral -4.0 according 
to the Allen atlas (http://www.brain-map.org/). Mice were anesthetized with 
isoflurane and placed in a stereotaxic frame. Bilateral injection into the 
basolateral amygdala was performed using a 10 µl syringe with a stainless steel 
needle. On each brain side, 500 nl of the virus were infused at a speed of 3 
nl/s. The needle was kept in place for 8 minutes after the infusion to improve 
the penetration of the viral solution into the tissue. As a control for the 
infection, additional mice were injected with the viral diluent solution (Sham) 
using the same protocol. The analgesic carprofen (5 mg/kg) was administered 
subcutaneously. After the surgery, mice were returned to their home cages and 
left to recover for 2 weeks. 
3.6  WESTERN BLOTTING (STUDY III) 
Following electrophysiological experiments hippocampal slices were 
homogenized in NP buffer (137mM NaCl, 20mM Tris, 1% NP-40, 10% 
glycerol, 48mM NaF, H2O, complete inhibitor mix (Roche), 2mM Na3VO4. 
After at least 15-minute incubation on ice, samples were centrifuged (16000g, 
15 min, +4°C) and supernatant collected for further analysis. Protein 
concentrations were measured using Bio-Rad DC protein assay (Bio-Rad 
Laboratories, Hercules, CA). Samples (25 μg protein) were separated with 
NuPAGe 4-12% Bis-Tris gel (Novex, life technologies, USA) and blotted to a 
polyvinylidene fluoride membrane (300mA, 1 hour, 4°C). Membranes were 
incubated with the following primary antibodies (Table 1): Synaptophysin 
(Sigma, USA, 1/200), Synaptotagmin (Sigma, USA, 1/1000), phospho-
Synaptotagmin (Sigma, USA, 1/1000), CaMKII (Millipore, USA, 1/1000), 
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phospho-CaMKII (Millipore, USA, 1/1000), Syntaxin 1A (Cell Signaling, USA, 
1/1000), CREB (Cell Signaling, USA, 1/1000), MUNC18 (Cell Signaling, USA, 
1/1000) diluted in 5% BSA on TBS/0.1% Tween (TBST). Further, the 
membranes were washed with TBST and incubated with horseradish 
peroxidase conjugated secondary antibodies (1:10000 in non-fat dry milk, 1 
hour at room temperature; Bio-Rad). After subsequent washes, secondary 
antibodies were visualized using enhanced chemiluminescence (ECL Plus, 
ThermoScientific, Vantaa, Finland) for detection by Fuji LAS-3000 camera 
(Tamro Medlabs, Vantaa, Finland). 
Table 1. Summary of all proteins analyzed in study III. 
Full name Short 
name 
Function related to LTP 
Synaptophysin SYP 
 
vesicular membrane protein 
(Mullany & Lynch 1998) 
Synaptotagmin 1 Sptg1 Ca2+-sensor for synaptic vesicle 
exocytosis (Ahmad et al. 2012) 
MUNC 18 MUNC 18 precede and/or regulate the 
formation of vesicles priming 
(Barclay 2008; Jurado et al. 2013) 
Syntaxin 1 Stx1 membrane component of SNARE 
complex (Mishima et al. 2014; Davis 
et al. 2000) 
Ca2+/calmodulin-
dependent protein kinase 
II 
CaMKII protein kinase, initiates LTP-
dependent Ca2+ cascade (Lisman 
1994) 
cAMP response element-
binding protein 
CREB transcription factor, control memory 
consolidation and late LTP phase 
(Kida 2012) 
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3.7  IMUNOHISTOCHEMISTRY (STUDY I, II) 
Immunostaining was performed using free-floating brain sections. After 
washing with PBS to remove the cryoprotective solution, the sections were 
incubated in a blocking reagent consisting of 5% goat serum (Vector 
Laboratories, UK), 3% bovine serum albumin (Sigma-Aldrich, Finland) and 
0.4% Triton X-100 (Sigma-Aldrich, Finland) in PBS to prevent nonspecific 
binding of antibodies. Before blocking, an antigen retrieval step including an 
incubation in 0.1% pepsin (Sigma-Aldrich, Finland) in 5 mM HCl for 10 min 
at room temperature, was performed to increase the binding of the primary 
antibodies for GABAARα1, GABAARα2 and VGLUT1. Sections were incubated 
with one of the primary antibodies (Table 2) in PBS containing 0.4% Triton 
X-100 (PBST) overnight at +4 °C. Then, sections were washed in PBST and 
incubated with the appropriate secondary antibodies (Molecular probes, 
Invitrogen, Espoo, Finland) for 1 h at room temperature. Finally, sections were 
mounted on slides and covered with Prolong®Gold anti-fade reagent with 
DAPI (Molecular Probes, Invitrogen, Espoo, Finland).  
 
Table 2. Summary of all proteins analyzed in study II. 
Protein Short 
name 
Function 
Synaptophysin SYP vesicular membrane protein 
GABA Transporter 1 Gat1 GABA plasma membrane transporter 
(Heldt & Ressler 2007) 
Glutamate receptor 1 GluA1 Ca2+-permeable AMPA receptor subunit 
(Clem & Huganir 2010) 
Glutamate receptor GluA2 Ca2+-impermeable AMPA receptor 
subunit (Kim et al. 2007) 
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Vesicular Glutamate 
Transporter 1 
VGLUT1 vesicle-bound, sodium- phosphate 
dependent glutamate transporter (Wojcik 
et al. 2004) 
Vesicular GABA and 
glycine transporter 
VGAT 
 
sodium- and chloride-dependent GABA 
transporter (Schoenfeld et al. 2013) 
GABA A Receptor 
alpha 1 
GABAARα1 subunit of GABAR which agonist produce 
sedative effect (B Luscher et al. 2011) 
GABA A Receptor 
alpha 2 
GABAARα2 subunit of GABAR which agonist produce 
anxiolytic effect (Bernhard Luscher et al. 
2011) 
NMDA receptor 2A GluN2A subunit of NMDARs abundantly 
expressed in adult brain (Walker et al. 
2002) 
Postsynaptic density 
protein 95 
PSD95 major scaffolding protein of the 
excitatory 
post-synaptic density (Fitzgerald et al. 
2015) 
3.8  ELECTROPHYSIOLOGY (STUDY III, IV) 
On the last day (21) of the Flx treatment or 24h after isoflurane exposurev mice 
were anaesthetized with pentobarbital (50mg/kg), decapitated and sagittal 
slices were cut from the hippocampi as described previously (Bortolotto et al. 
1999). The slices were allowed to recover for 1-4 hours before the recordings 
were started. All recordings were done in an interface-type chamber (+32C°) 
which was constantly perfused with artificial cerebrospinal fluid (ACSF) 
containing (in mM): NaCl 124, KCl 3, NaH2PO4 1,25, MgSO4 4, NaHCO3 26, 
D-glucose 15, CaCl2 2, and gassed with 5% CO2/95% O2. Field excitatory 
postsynaptic potentials (fEPSP) were evoked with bipolar stimulating 
electrode placed within the Schaffer collateral pathway and the responses 
were recorded from CA1 stratum radiatum using ACSF-filled glass 
microelectrodes (2–5 MΩ). For baseline recordings square pulse (0.05 
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Hz/0.1) ms stimulation protocol was used. Input/output (I/O) curves were 
constructed using gradually increased stimulation intensities until the fEPSP 
reached plateau or visible population spike was seen. After I/O data were 
collected, the stimulus intensity was adjusted to evoke half-maximal (40-
60%) fEPSP response. Long-term potentiation (LTP) was induced 10-15 
minutes after baseline recording by 100Hz/1s tetanic stimulation. Post-
induction responses were normalized to the final 10 min of the baseline 
recordings. The level of LTP was measured as a percentage increase of the 
fEPSP slope, averaged at a 1-min interval 50-60 min after the tetanus, and 
compared to the averaged baseline fEPSP slope recorded before tetanus. To 
examine short term plasticity we performed paired-pulse- (PPF) and 
frequency facilitation (FF) experiments. In PPF experiments interpulse 
intervals of 20, 60, 100, 150 and 200 ms were used. In FF experiments 100 
pulses with either 1 or 100 Hz were applied.  
 
3.9  DATA ACQUISITION AND STATISTICAL ANALYSIS 
Behavioral study  
Statistical analyses of the behavioral tests were performed using repeated-
measures ANOVA followed by Student’s paired or unpaired two tailed t-test. 
For the post-hoc matching analysis, the subjects with exactly matching the 
freezing levels at the “Acquisition” time point in control and Flx groups were 
selected. The bivariate Pearson's correlation and linear regression analyses 
were performed using Origin (OriginLab, Northampton, MA). A P-value < 
0.05 was considered statistically significant. 
Immunohistological study 
Quantitative evaluation of immunostainings was performed by an investigator 
blind to the treatment groups; all slides were coded until the analyses were 
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finished. The images were obtained by the Imager M.1 fluorescent microscope 
(Zeiss, Germany) using AxioVision software. A minimum of 5 sections per 
brain area/per animal, as well as control sections “No primary antibody”, were 
imaged using the same microscope and camera settings for all slides within 
each immunostaining experiment. Image processing was performed with 
ImageJ software. To estimate the difference in expression of proteins, brain 
regions were delineated and mean optical densities were measured. The mean 
optical densities of the controls “No primary antibody” were subtracted from 
obtained values for every brain area in all immunostaining experiments. All 
the values present as mean ± SEM and as percentage of control. Statistical 
analyses of protein levels were performed in Origin (OriginLab, Northampton, 
MA) using a two-way ANOVA with a post hoc Fisher's PLSD test. A p-
value<0.05 was considered statistically significant. 
Electrophysiological study 
WinLTP (www.winltp.com) program was used for electrophysiological data 
acquisition and analysis. All the data are expressed as mean ± SEM and as 
percentage of control. For statistical analysis of I/O, PPF, LTP and FF two-
way ANOVA for repeated measures were implemented. All statistical analyses 
were done using Origin (OriginLab, Northampton, MA). A p-value<0.05 was 
considered statistically significant. 
Molecular biological study 
Immunoblot bands were quantified using NIH ImageJ. All the data are 
expressed as mean ± SEM and as percentage of control. Statistical analyses 
were performed using Origin (OriginLab, Northampton, MA). For comparison 
between groups two-way ANOVA was used. The criterion for significance was 
set to p<0.05. 
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4. RESULTS 
 
4.1 IPLASTICITY IN PATHOLOGY (STUDY I, II) 
 
In order to study how plasticity induced by Flx account for successful recovery 
from fearful memories, we subjected mice to fear conditioning and then 
applied chronic Flx treatment. We analyzed how Flx administration 
influenced fear erasure and affected spontaneous fear renewal and recovery. 
After successful fear acquisition, the mice were given either Flx or water for 
two weeks. Thereafter, both groups were subjected to extinction training and 
seven days later, the mice were tested for spontaneous recovery and fear 
renewal (study I, fig 2). This paradigm was utilized to explore whether fear 
reduction was permanent. Although fear extinction was seen in both control 
and Flx-treated animals, Flx-treated mice showed significantly faster 
extinction. However, whilst the control mice showed clear fear renewal and a 
tendency to spontaneous recovery, the Flx-treated mice showed no signs of 
renewal or spontaneous recovery. Moreover, mice not exposed to extinction 
training showed enhanced freezing regardless of their treatment group. Next, 
we examined the effect of Flx on fear reinstatement (study I, fig. 2). After 
successful extinction in the fear-conditioning context, mice were exposed to a 
foot shock five times without a CS and tested for freezing after a tone 24 hours 
later. Control mice showed a robust fear reinstatement whereas freezing in 
mice receiving Flx was significantly reduced. Our results highlight a previously 
undescribed principle of AD-treatment whereby long-term loss of fearful 
memories can be induced only by combined chronic Flx administration and 
extinction training.  
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In addition to the behavior study, we investigated whether Flx, extinction or 
their combination produced long-lasting changes in the expression of synaptic 
proteins in the well-studied fear networks: amygdala, hippocampus and 
mPFC (study II) (Quirk et al. 2010). We found extinction dependent and 
independent changes in the expression profile of pre- and postsynaptic 
proteins involved in glutamatergic and GABAergic synaptic transmission 
(study II, table I). 
We found that fear conditioning significantly downregulated VGLUT1 and 
GABAARα1 expression induced by fear conditioning in the hippocampus and 
mPFC, and that chronic Flx-treatment accentuated these effects (study II, fig. 
3). However, if combined with extinction training, Flx enhanced the 
expression of SYP in all investigated brain areas (study II, fig. 3). 
Concomitantly, the expression of VGLUT1, PSD95, GluN2A and GluA2 was 
increased in the amygdala and hippocampus (study II, fig. 3). Moreover, Flx 
increased the expression of both investigated GABAARs subunits in the mPFC 
and amygdala (study II, fig. 3). Thus, we demonstrated that combination of 
Flx and extinction treatments form a specific synaptic landscape permissive 
for long-term fear extinction facilitation and fear erasure in adult mice. 
 
4.1.1  FEAR ERASURE DEPENDS ON BDNF IN AMYGDALA (STUDY I) 
Chronic Flx treatment alone increased BDNF expression in many brain areas 
and after fear conditioning significantly increased BDNF mRNA level in the 
basolateral amygdala (BLA) (study I, fig 4A). To test whether overexpression 
of BDNF in the basolateral amygdala mimics Flx exposure, we used 
doxycycline regulated lentiviral infection to overexpress BDNF locally in the 
BLA from the end of extinction onward (study I, figs. S8 and S9). We showed 
that BDNF-overexpressing mice did not show fear renewal, induced through 
conditioned CS presentations in extinction and conditioning contexts, 
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whereas control mice showed robust freezing behavior following fear renewal 
(study I, fig. 4C). Thus, successful fear erasure depends on BDNF expression 
in amygdala. 
 
4.2 IPLASTICITY IN HEALTH (STUDY I, III, IV) 
 
4.2.1  FLX INDUCES IPLASTICITY IN NAÏVE MICE (STUDY I, III) 
In order to investigate the mechanism of Flx induced neuronal network 
tuning, we performed experiments on naïve/healthy mice. In study I, in 
addition to the clinically relevant administration after exposure to fear, we 
tested an alternative paradigm of chronic Flx administration which precedes 
fear induction. Interestingly, we found that pre-treatment with Flx, as 
observed when Flx was applied after exposure to fear, did result in faster fear 
extinction (study I, fig. 2). In order to examine behavior sensitivity to chronic 
Flx in naïve mice, we tested mice digging activities using the marble burying 
test (study III). It was previously shown that mice digging behavior is sensitive 
to a variety of treatments, including anxiolytic drugs and serotonin-active 
compounds (Deacon 2006). We found that mice subjected to FLX 
administration exhibited significantly less burying activities compared to 
control animals (fig. 3). These results suggest that Flx not only promote 
recovery after pathological cues but apparently predisposes neuronal 
networks to cope with forthcoming pathological events.  
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Figure 3. Fluoxetine treatment 
reduced marble burying behavior. 
Black bars-water treated animals, 
white bars-Flx treated animals 
 
To evaluate the effect of Flx on naïve mice, we investigated the expression of 
histological neuroplasticity markers in hippocampal CA1 area, BLA, prelimbic 
and infralimbic mPFC (PL, IL). We found that chronic Flx did not change the 
absolute numbers of PNN-positive neurons in the BLA, hippocampal CA1 
area, and IL (study I, fig. 3A, B and table S1). However, Flx treatment reduced 
the percentage of PNN neurons expressing parvalbumin in both the BLA and 
CA1 area of hippocampus (study I, fig. 3A, B), whereas no differences were 
found in PNN-positive interneurons containing calbindin or calretinin (study 
I, fig. S5 and table S1). Expression of PSA-NCAM, which is expressed in 
immature cortical cells and reduced with maturation, was increased by Flx 
treatment in the BLA (study I, fig. 3C). Concomitantly, Flx treatment reduced 
the expression of the K-Cl cotransporter KCC2 (study I, fig. 3D), which 
increases during postnatal development. All together, these data suggest that 
Flx induces plasticity in naïve mice, which can contribute to/explain the 
robust Flx effects on neuronal network reinstatement under pathological 
conditions (study I, II).  
4.2.2  FLX FACILITATES SYNAPTIC PLASTICITY (STUDY III) 
The results from studies I and II strongly suggested that Flx may affect the 
synaptic machinery involved in use-dependent synaptic plasticity in limbic 
areas. Therefore, we next studied the effects of Flx on neuronal transmission 
and plasticity at glutamatergic synapses in the area CA1 of the hippocampus. 
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Here, fEPSPs, evoked by Schaffer collateral stimulation, were recorded in the 
CA1 area of hippocampus. We found that chronic Flx treatment shifted the 
input-output curve to the left (study III, fig. 1A) thus implicating enhanced 
basal glutamatergic transmission. Moreover, LTP induced by tetanic 
stimulation (100st/1sec) was more prominent in hippocampal slices from Flx-
treated mice (study III, fig. 2A). In parallel, PPF at 20ms and 50ms intervals 
as well as frequency facilitation (FF) by 1Hz/100 pulse and 100Hz/100 pulse 
stimulation protocols were both increased after Flx-treatment (study III, fig. 
3, B and fig. 2.D).  
We next investigated whether changes in the expression of synaptic proteins 
paralleled changes in synaptic function. To determine the molecular basis of 
activity dependent alterations in synaptic plasticity induced by Flx, we 
measured the expression levels of proteins related to vesicular trafficking and 
release and important mediators of LTP. Expression of investigated proteins 
was estimated with Western blotting in hippocampal slices where LTP was 
induced and maintained for 60 min; as a control, slices with 0.05Hz 
stimulation maintained under the same conditions were used. 
We demonstrated that phosphorylation of CaMKII was enhanced in vehicle 
and Flx treated animals after LTP induction (study III, fig. 3A), while levels of 
CREB phosphorylation was increased by Flx treatment in control slices and 
after LTP in vehicle treated animals (study III, fig. 3B). Moreover, Flx 
accentuated expression of SYP, Sptg1, Stx 1 and MUNC 18 and also enhanced 
expression of SYP and Sptg1 in an activity-dependent manner (only after LTP) 
(study III, fig. 5). Thus, Flx administration predisposes hippocampal networks 
to activity-dependent plasticity, which is associated with accentuated 
presynaptic function and enhanced expression level of proteins related to 
vesicles trafficking and release. 
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4.2.3  ISOFLURANE IPLASTICITY (STUDY IV) 
We found that brief isoflurane anesthesia induced rapid antidepressant-like 
effects: increased TrkB phosphorylation in the mouse mPFC, hippocampus 
and somatosensory cortex (study IV, fig. 1A-B, supplementary fig. 1-4). 
Isoflurane also rapidly activated the downstream signaling cascade of TrkB: 
induced the phosphorylation of CREB, Akt, mTOR and its downstream kinase 
p70S6K in the mouse mPFC (study IV, fig. 1C-F; supplementary fig. 5). 
Phosphorylation of CREB and p70S6K, but not Akt or mTOR, was also 
observed in the hippocampus (study IV, supplementary fig. 1). However, 
isoflurane had no rapid effects on BDNF mRNA or protein levels (study IV, 
supplementary fig. 6). Our molecular findings concerning isoflurane-induced 
neuronal plasticity was associated with changes in behavior. Thus, mice 
anesthetized with isoflurane for 30 min and tested 15 minutes later showed 
reduced immobility and increased latency to immobility (study IV, fig. 2A; 
supplementary fig. 7A) in the FST. Strikingly, when the isoflurane-treated 
mice were retested two weeks later, an antidepressant-like phenotype was still 
observed (study IV, fig. 2B; supplementary fig. 7B).  
We also demonstrated that the rapid antidepressant actions of isoflurane were 
associated with changes in synaptic plasticity. Tetanic stimulation (100Hz/1s) 
of the Schaffer collateral produced significantly higher levels of long-term 
potentiation of fEPSPs in slices prepared from mice treated with isoflurane 24 
hours before experiments than in the control slices (study IV, fig. 3A). 
Recordings of the input–output relationship showed that isoflurane exposure 
24 hours before accentuated basal synaptic transmission in the hippocampus 
(study IV, fig. 3B). PPF was not affected by isoflurane indicating unaltered 
presynaptic function. Thus, our results demonstrate that single brief 
isoflurane anesthesia results in iPlasticity-type tuning of neuronal networks 
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which, in turn, may explain the antidepressant-like action and efficacy of 
isoflurane. 
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5. DISCUSSION 
 
The aim of this thesis was at advance our understanding of the mechanisms 
associated with iPlasticity. Employing a wide range of techniques, we 
attempted to demonstrate how different pharmacological agents enhance 
synaptic plasticity and lead to behavior improvements in normal and 
pathological states in mice. 
 
5.1 FLX AS AN ANTIDEPRESSANT 
 
The clinical efficacy of Flx as antidepressant was demonstrated in many 
studies (Gaynes et al. 2009; Fournier et al. 2010). Initially, understanding of 
the underlying mechanism of action was associated with the reinstatement of 
monoamine deficit induced by pathological conditions. However, he plasticity 
hypothesis currently dominates explanations of the mode of Flx action.  
Extinction training during a critical period in juvenile mice leads to 
permanent fear erasure (Gogolla et al. 2009; Kim & Richardson 2010). Since 
the antidepressant Flx induced plasticity in the visual cortex (Maya 
Vetencourt et al. 2008), we attempted to investigate whether reactivation of 
iPlasticity by Flx will lead to long term fear erasure if treatment alone is 
introduced or in combination with extinction treatment. We showed that 
chronic Flx treatment, given three weeks before or after exposure to FC, did 
cause faster extinction. Moreover, we demonstrated that these changes were 
permanent, because recovery, renewal and reinstatement of fear were 
attenuated in mice treated with Flx. In a pre-clinical investigation in mice by 
I. Branchi and colleagues, Flx administration, given in the enriched 
environment after exposure to chronic unpredictable stress (CUS), increased 
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saccharin preference, BDNF levels and decreased corticosterone which would 
account for the reduction of stress-induced symptoms observed. However, if 
Flx is given in a stressful environment, it lead to worse behavior outcomes 
(Branchi et al. 2013). Together with our findings, it is evident that the effect of 
Flx is not determined by drug per se but induced by the drug and driven by 
environment. 
In parallel with the behavioral assessments of fear-conditioned mice, we 
demonstrated that the combination of Flx and extinction treatments formed a 
specific synaptic landscape permissive for long-term fear extinction 
facilitation and fear erasure in adult mice. We found that stress induced by 
fear conditioning had a long-lasting inhibitory effect on the expression of 
proteins related to excitatory transmissions: SYP and GluA2 in the 
hippocampal CA1 pyramidal layer and VGLUT1 in the whole hippocampus of 
both water-and Flx-treated animals. Previously it was demonstrated that 
exercise induces a switch from GluA2-containing to GluA2-lacking AMPA 
receptors (Park et al. 2014; Middei et al. 2014; Gan et al. 2015), which are 
commonly referred to as calcium-permeable (CP-AMPA receptors). Thus, 
transient CP-AMPAR expression may provide an important Ca2+ entry 
mechanism during synapse maturation and impart distinct short/long-term 
plastic properties to neuronal networks (Rozov & Burnashev 1999; Liu & Cull-
Candy 2000). 
We demonstrated that fear conditioning affected GABAergic transmission: 
reduced VGAT and sedation-associated GABAAR α1 expression in water 
drinking mice and down-regulated expression of anxiolytic GABAAR α2 in Flx 
treated animals. These data are very much in line with the finding where 
reduced glutamate function, due to VGLUT1 deficiency (Wojcik et al. 2004) or 
decreased GABA-receptor function was specifically implicated in anxiety and 
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fear-related disorders and depression- like behaviors (Tordera et al. 2005; 
Luscher et al. 2011). 
Surprisingly, we could not detect robust changes in the expression profile of 
investigated proteins if Flx treatment alone was introduced after fear 
conditioning, whereas extinction affected the levels of synaptic protein 
expression much stronger then Flx treatment alone. Whilst Flx treatment, 
given after FC downregulated expression of GABAARα2 in PFC and further 
reduced expression of VGLUT1 in the hippocampus, extinction alone 
enhanced expression of PSD 95 in BLA, VGAT in all investigated brain areas, 
GAT and GABAARα1 in PFC and downregulated the expression of GABAARα2 
and GluA1:GluA2 ratio in amygdala. 
We hypothesize that Flx iPlasticity promotes the effects of behavioral 
experience, such as extinction training. This, in turn, helps to reshape 
maladapted networks to better adjust to the environment. Therefore, our 
results provide a putative neurobiological basis for the enhanced effect of 
combining drug and psychological treatments and support the hypothesis that 
the chemical effect produced by administering antidepressants alone will not 
give full clinical benefit (Moncrieff & Kirsch 2005; Turner et al. 2008; Kirsch 
et al. 2008). Instead, drug treatments need to be combined with 
psychotherapy or other kinds of rehabilitation to optimize their mood-
elevating effects.  
In contrast, we found that combination of chronic Flx with extinction therapy 
resulted in a unique long-lasting remodeling of synaptic proteins expression. 
The synergic effect of Flx and extinction treatment was associated with 
enhanced GluN2A expression which is in agreement with a previous study, 
where D-cycloserine, an NMDA-receptor partial agonist, administration 
facilitated GluN2A expression and lead to successful fear erasure after FC 
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(Walker et al. 2002; Lin et al. 2010). Another important finding, associated 
with the formation of unique synaptic protein profiles, is accentuated 
expression of proteins related to glutamatergic transmission (VGLUT1, 
PSD95, GluN2A, and GluA1) and a mild change in inhibitory component of 
synaptic transmission, when compared to the effect of extinction alone. To 
address this question we further tested influence of Flx action on neuronal 
networks in naïve mode. 
 
5.2 MECHANISMS OF FLX IPLASTICITY 
 
5.2.1  FLX AND STRUCTURAL PLASTICITY 
To understand the properties of Flx iPlasticity we investigated the effect of Flx 
administration on structural plasticity in the healthy state. Different 
molecules may mediate structural plasticity of neurons, particularly those 
involved in cell adhesion. Polysialated neuronal cell-adhesion molecule (PSA-
NCAM) is expressed in immature cortical cells and reduced with maturation. 
PSA-NCAM-expressing neurons receive less synaptic contacts than those 
lacking this molecule and have reduced dendritic arborization and spine 
density (Nacher et al. 2002; Guirado et al. 2014), suggesting that PSA-NCAM 
plays a role in the developmental regulation of neuronal structure and 
function. In our study we observed that Flx administration increased PSA-
NCAM expression in the basolateral amygdala (Fig. 3C, study I) In line with 
this findings, we demonstrated that Flx treatment reduced the expression of 
the K-Cl cotransporter KCC2 (Fig. 3D, study I), which is a key molecule 
responsible for the developmental switch from GABAA receptor -mediated 
depolarising to hyperpolarising action and whose expression dramatically 
increases with maturation of inhibitory systems (Rivera et al. 1999). 
Previously, it was demonstrated that disruption of PNNs with chondroitinease 
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ABC in the adult basolateral amygdala before, but not after, fear conditioning 
leads to fear erasure after extinction (Gogolla et al. 2009). In our study we 
assessed whether Flx treatment might disrupt PNNs and thereby facilitate 
extinction. Control and Flx-treated mice had similar numbers of PNN-positive 
neurons in all investigated brain areas. However, Flx treatment reduced the 
percentage of PNNs neurons expressing PV in the BLA and CA1 area of 
hippocampus. Previously, it was proposed that the developmental increase in 
PNNs may limit PV cells plasticity to allow these cells to strongly coordinate 
neuronal network through intense firing (Roux & Buzsáki 2015). These data 
suggest that Flx treatment selectively shifts the parvalbumin- and PNNs-
containing neurons toward an immature state. Taken together we conclude 
that Flx iPlasticity induced a structural reorganisation of investigated 
neuronal networks which may form the basis for behavior improvements. 
 
5.2.2  FLX AND SYNAPTIC PLASTICITY  
Long-term plasticity can be bi-directionally modified by various cues. For 
example, enhanced LTP is observed after exposure to enriched environment 
and is associated with improved learning and memory. Other exposures, like 
chronic unpredictable stress, in turn suppress or block long term potentiation 
(Alfarez et al. 2003). In spite of having only two possible directions of change, 
the basis of such LTP regulation could vary greatly. We demonstrated in our 
study that chronic antidepressant Flx administration enhances basal synaptic 
transmission and long term plasticity in hippocampal CA3-CA1 synapses. 
Moreover we showed that LTP changes were accompanied with alterations in 
short term synaptic plasticity and dynamics in CA1 hippocampal synapses. To 
investigate short term synaptic plasticity, we measured paired pulse 
facilitation and frequency facilitation, which are frequently used to assess 
changes in underlying. We found that Flx alter Pr and frequency facilitation. 
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Flx action on presynaptic function was previously reported. Thus it was 
demonstrated that Flx restores depolarization-evoked glutamate release in 
hippocampus in animals exposed to prenatal stress (Marrocco et al. 2014), 
and increases the frequency of spontaneous EPSCs in the locus coeruleus. We 
hypothesize that altered by Flx Pr might give the synapses considerable leeway 
so the property of synaptic transmission can be carefully regulated. All 
together, these findings demonstrate that Flx enhance synaptic plasticity and 
one of the possible sources of such modulations could be altered presynaptic 
function.  
We reported in our study that NMDA-dependent LTP (Kauer et al. 1988; 
Malenka et al. 1989) was enhanced after Flx in CA3-CA1 hippocampal 
synapses. However, there is considerable controversy regarding the effects of 
Flx on long-term synaptic plasticity. (Stewart & Reid 2000; Kobayashi et al. 
2010; Rubio et al. 2013). The studies by Stewart and Reid, and Rubio and co-
authors demonstrated that chronic Flx down-regulated long term synaptic 
plasticity in perforant path – DG synapses and CA3-CA1 hippocampal 
synapses, respectively. In the above experiments almost 20-fold lower dose of 
Flx treatment was employed, whereas in our study clinically relevant 
20mg/kg/day dose of Flx treatment was used in order to reach same level of 
plasma Flx level as patients taking 20–80 mg Flx (Prozac) per day (Dulawa et 
al. 2004). In line with our data, several studies (Wang et al. 2008; Sale et al. 
2007; Maya Vetencourt et al. 2008; Karpova et al. 2011) show that long term 
Flx administration enhances LTP in cerebral cortex, hippocampal perforant 
path and BLA and these findings were accompanied by altered maturation and 
survival of immature neurons in DG and enhanced expression of several 
plasticity-related markers. 
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Figure 4. Molecular protein complex that organize the secretory machinery at the 
presynaptic active zone.  
 
To investigate possible mechanism underlying altered synaptic plasticity, we 
measured expression of key downstream signaling molecules related to LTP: 
CaMKII/pCaMKII and CREB/pCREB and proteins associated with vesicular 
trafficking and release: synaptophysin, synaptotagmin 1, MUNC18 and 
Syntaxin1 (Fig.4). We also probed whether its expression depends on network 
activity by performing western blotting on slices from vehicle (water) and Flx 
treated animals where LTP was induced and maintained for 60min, (with 
control slices subjected to basal (0.05 Hz) stimulation only). CaMKII and 
CREB are involved in synaptic plasticity and have been previously shown to 
be targets of antidepressants (Celano et al. 2003; Tiraboschi et al. 2004; 
Bonanno et al. 2005; Barbiero et al. 2007). We found no difference in the 
expression of total CaMKII and CREB. Even though phosphorylation of both 
proteins was enhanced by LTP, the levels of phosphorylation were 
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unexpectedly lower in Flx treated animals than in vehicle treated ones. We 
conclude that synaptic plasticity enhanced by Flx is not associated with 
enhanced expression of downstream signaling molecules responsible for LTP. 
There are two possible explanations for these results, Flx: 1) recruits other 
downstream signaling proteins or 2) modulates synaptic plasticity in 
alternative way. Since our electrophysiological experiments identified changes 
in presynaptic function by Flx treatment, we probed a second hypothesis and 
measured expression of proteins related to vesicular trafficking and release. 
We choose synaptophysin, synaptotagmin, MUNC 18 and synatxin 1 because 
their roles in distinct stages of vesicles priming and fusion with the plasma 
membrane (fig. 4, table 2). SYP marks most of the vesicles in the brain. 
Synaptotagmin 1 acts as a Ca2+-sensor for synaptic vesicle exocytosis. MUNC 
18 regulates vesicle priming and Syntaxin 1, as part of membrane SNARE 
complex, reflects the overall amount of active zones. Our experiments showed 
that levels of expression of all investigated proteins were significantly higher 
in Flx treated mice then in controls. Interestingly, enhanced expression of SYP 
and Sptg1 was activity dependent and was enhanced only on slices from Flx 
treated animals where LTP was induced.  
Even though we cannot exclude other possible explanations to account for 
LTP enhancement, we have indirect evidence that suggests the changes 
observed in synaptic plasticity following chronic Flx administration: 1) are 
associated with accentuated presynaptic function 2) partially emerged in an 
activity-dependent manner. In study I we showed that only a combination of 
Flx treatment with extinction therapy (but not treatment alone) produces 
behavior outcomes. Moreover, in study II we demonstrated that Flx in 
combination with extinction treatment resulted in enhanced expression of 
SYP, VGLUT1, PSD 95 and GluN2A. Thus, we propose thatlong-term Flx 
administration might predispose hippocampal networks to activity-
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dependent plasticity, which is associated with accentuated long term synaptic 
plasticity and altered presynaptic function. 
It is not clear why Flx, with its pronounced acute effect on neuronal networks 
(Rantamäki et al. 2007; Sung et al. 2008; Kim et al. 2013; Jung et al. 2014), 
induces iPlasticity only following chronic administration and, thereby, 
offering potential therapeutic outcomes to a variety of mental disorders. It is 
well known that the CA1 area of hippocampus is highly innervated by 
serotonergic inputs. Direct stimulation of raphe nuclei or local serotonin 
application (Otmakhova et al. 2005) results in suppressed excitatory synaptic 
transmission in CA1 pyramidal cells. Flx applied acutely to slices suppresses 
synaptic transmission and blocks LTP induction (Shakesby et al. 2002). 
However, chronic Flx administration not only enhances basal synaptic 
transmission, short and long-term synaptic plasticity, but also stimulates 
maturation and synaptic plasticity of adult born hippocampal granule cells 
(Wang et al. 2008), alters specific inhibitory circuits of hippocampus (Méndez 
et al. 2012) and restores juvenile-like plasticity in the visual cortex and BLA 
(Maya Vetencourt et al. 2008; Karpova et al. 2011) . Such adaptive responses 
support the idea of homeostatic synaptic scaling (Turrigiano et al. 1998) 
induced by long term elevation through blockade of serotonin reuptake by Flx. 
Prolonged shunting of excitatory synaptic transmission may cause adaptive 
homeostatic responses aimed at balancing changed properties of synaptic 
transmission by inducing plasticity in the brain. So enhanced long and short 
term synaptic plasticity induced by Flx may be nothing but adaptive tuning of 
the hippocampal network oriented to the reinstatement of 
inhibitory/excitatory balance after long-term serotonin augmentation and the 
so-called plasticity changes that we observe appear to be a consequence of an 
underlying homeostatic regulation induced by chronic Flx administration. 
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5.3 ISOFLURANE IPLASTICITY 
 
In study IV, we assessed the role of another frequently used pharmacological 
compound, the volatile anesthetic Isoflurane, in iPlasticity. We found that 
brief isoflurane anesthesia induced a rapid and transient phosphorylation of 
TrkB and activation of CREB, Act and mTOR in different brain areas that have 
been linked to the antidepressant-like behavior in rodents. To elucidate the 
mechanisms underlying the rapid antidepressant actions of isoflurane, we 
examined synaptic plasticity and found that a single isoflurane 
administration, 24 hours before electrophysiological recordings, enhanced 
LTP and accentuated basal synaptic transmission in the CA3-CA1 
hippocampal synapses (Fig. 3B, study 4). PPF was not affected by isoflurane 
indicating unaltered Pr and presynaptic function (Supplementary Fig. 10, 
study 4). These effects of isoflurane on synaptic strength resemble those of the 
antidepressant Flx: 1) antidepressant effects on behavior, 2) dependent on 
TrkB signalling, 3) enhanced basal synaptic transmission and long term 
synaptic plasticity. But to achieve all the indicated changes, long term Flx 
treatment is needed, whereas for isoflurane induced plasticity only a single 
exposure is required. Therefore, isoflurane action on neuronal networks more 
closely resembles the action of another compound with fast-acting properties 
on the nervous system - ketamine. Together with ketamine (Autry et al. 2011), 
isoflurane induced iPlasticity following a single administration, activates 
mTOR and lead to synaptic plasticity. However there are concerns that 
ketamine’s addictive and psychotomimetic properties will hinder it from 
reaching its potential to treat human depression, while use of isoflurane in 
clinics is promising. It was already reported previously, that isoflurane 
produce rapid antidepressant effects in treatment-resistant depressed 
patients (Langer et al. 1985). We believe that isoflurane, with its ability to 
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quickly induce synaptic plasticity and antidepressant-like action will become 
a good substitute for a) ketamine as it is devoid of its psychotomimetic side 
effects and b) Flx with its time consuming action. Moreover this opens new 
potentials for clinical research in the field of human neuropsychiatric 
disorders where application of fast-acting antidepressants, alone or in 
combination with psychotherapy, might emerge as a therapeutic strategy in 
the near future. 
 
5.4 SPECIFIC VS COMMON FEATURES OF FLX AND 
ISOFLURANE IPLASTICITY 
 
As demonstrated, the investigated compounds, Flx and isoflurane, affected 
many aspects of neuronal plasticity and both induced synaptic plasticity. We 
showed that chronic Flx and single isoflurane exposure activated TrkB 
receptor and enhanced LTP. Moreover based on our results, we conclude that 
these compounds resulted in iPlasticity and can be used as tools to study it. 
However, not all the features of Flx and isoflurane iPlasticity are similar. First 
of all, to achieve behavior benefits, long term Flx administration is required. 
However for isoflurane action, only a single brief exposure is needed. A large 
number of studies into the action of Flx on the nervous system allow us to 
speculate that plasticity induced by Flx may be associated with homeostatic 
tuning of neuronal networks oriented to reinstate the inhibitory/excitatory 
balance caused by long-term serotonin augmentation. The poor knowledge 
concerning the action of isoflurane on the nervous system and relatively young 
field of fast acting antidepressants provides little insight into its role in rapid 
plasticity stimulation. More diversity arises from the effect of investigated 
drugs on BDNF expression. It is very well known that long term 
administration of Flx increases levels of BDNF and some of its action on 
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neuronal networks are BDNF dependent. Isoflurane, in turn, does not change 
BDNF levels. Taking into account that both investigated chemical compounds 
induce TrkB phosphorylation, the key receptor of BDNF, our findings propose 
different plasticity mechanisms underlie iPlasticity. In accordance with this 
hypothesis, our results may be dependent on the difference in effect of Flx and 
isoflurane on GABA function. As previously reported, isoflurane and Flx exert 
persistent effects on GABAergic transmission (Harauzov et al. 2010; Méndez 
et al. 2012; Guirado et al. 2014; Zurek et al. 2014). In our experiments 
(unpublished, fig. 5) designed to explore the origin of LTP changes and probe 
whether synaptic plasticity induced by Flx and isoflurane depends on 
GABAergic function, we measured LTP in presence of the GABAAR antagonist, 
picrotoxin (PiX). Surprisingly, we observed that whilst Flx induced LTP 
enhancement remained unchanged, isoflurane induced alterations in LTP 
were diminished in CA1 area of hippocampus. 
 
Figure 5. LTP induced by tetanic stimulation (100 Hz) in CA3-CA1 hippocampal synapses 
in presence of picrotoxin, study on Flx treated mice (A) and isoflurane treated mice (B). 
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6. CONCLUSIONS 
 
In the present thesis, we described and analyzed a novel type of neuronal 
plasticity (iPlasticity), which, according to it features, resembles critical period 
plasticity but originates in the adult brain and required intense environmental 
or/and pharmacological guidance. To stimulate iPlasticity in our research we 
applied chronic treatment with antidepressant Flx and single brief exposure 
with volatile anesthetic isoflurane. We investigated the influence of this 
chemical compounds in pathology and health in mice. 
1. Using parallel behavior and immunohistochemical approaches in fear 
conditioning paradigm, we demonstrated that for successful fear erasure, 
combination of chronic Flx administration with extinction treatment is 
required. Our findings resemble the principles of neuronal network tuning 
during critical periods, where establishing of proper network function is 
driven by environment. Thus we affirmed that Flx iPlasticity resembles critical 
period plasticity and manifested as juvenile-like plasticity or reopened critical 
periods. 
2. We demonstrated that both investigated chemical compounds induced 
iPlasticity in naïve mice. Our immunohistochemical and molecular biological 
studies showed that Flx induced structural plasticity and stimulated BDNF-
TrkB interaction and signaling, whereas isoflurane also stimulated TrkB and 
other plasticity related signaling but didn’t influence BDNF expression. All 
findings were not restricted to certain brain region but were detected in 
different brain areas. 
3. Enhanced synaptic plasticity was observed after Flx and isoflurane 
administration. Both drugs facilitated synaptic transmission and long term 
plasticity in CA3-CA1 hippocampal synapses, however differently affected 
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short term synaptic plasticity. Moreover in experiments with picrotoxin we 
detected GABA dependent (isoflurane) and independent (Flx) drugs action on 
synaptic plasticity. 
In summary, in our studies we highlighted the principles and attempted to 
elucidate the mechanisms of iPlasticity. We demonstrated that iPlasticity 
induced by the investigated compounds underlie successful recovery from 
pathological cues and, in naïve animals, results in structural and functional 
reorganizations of neuronal networks suggesting that iPlasticity predisposes 
neurons to activity dependent changes. We also demonstrated that features of 
iPlasticity induced by Flx and isoflurane were not identical. Since both drugs 
are of particular use in humans, we expect our results will promote 
development and improve clinical strategies and practice in the use of these 
drugs.  
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